Navigation Links
ArteFill 5-Year Data to Be Presented at American Society for,Aesthetic Plastic Surgery Annual Meeting

SAN DIEGO--(BUSINESS WIRE)--Apr 17, 2007 - Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced that the final 5-year safety and efficacy data for ArteFill(R), the Company's FDA-approved non-resorbable injectable dermal filler will be presented at the national meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) on April 20, 2007 in New York City by Steven R. Cohen, MD, FACS, Clinical Professor, Division of Plastic Surgery, University of California, San Diego, School of Medicine and lead ArteFill clinical investigator. The session will also include a live patient workshop to demonstrate the proper techniques in the treatment of nasolabial folds (smile lines).

The 5-year clinical data represents the culmination of a significant follow-up study of 145 patients who were treated with ArteFill in the Company's U.S. clinical trial. The Company has submitted the data to the FDA in order to enhance the product labeling of ArteFill.

About ArteFill(R)

ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of wrinkles known as smile lines or nasolabial folds. The unique microspheres in ArteFill are not absorbed by the body and therefore provide the first-of-its-kind permanent support for long-lasting wrinkle correction in one to two treatments.

ArteFill was approved by the FDA in October 2006 based on data from the Company's 12-month controlled, randomized, double-masked, multi-center U.S. clinical trial, which compared outcomes for patients treated with ArteFill with those of patients treated with the leading bovine collagen-based filler. At the 6-month evaluation, which was the primary efficacy evaluation period for the clinical trial, the wrinkle correction in patients treated with Arte
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:4/16/2015)... -- A drug commonly taken to prevent seizures in epilepsy ... (MS), according to a study released today that will be ... in Washington, DC , April 18 to ... MS experience at some point in their life a condition ... from the eye to the brain gets inflamed," said study ...
(Date:4/16/2015)... , April 16, 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ... ended March 31, 2015 on Wednesday, May 6, 2015, following ... also host an investor conference call and live webcast on ... a company update and discuss the financial results.  ... www.alexza.com , under the "Investors" link.  Please log onto ...
(Date:4/16/2015)... DUBLIN , April 16, 2015 ... specialty biopharmaceutical company, today announced that it has ... purchase price of approximately $2.3 billion. The Ikaria ... and expands its reach into neonatal critical care ... vital treatment option for a highly vulnerable patient ...
Breaking Medicine Technology:Epilepsy Drug May Preserve Eyesight for People with MS 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... Jan. 11, 2011 Reportlinker.com announces that a ... catalogue: Johnson & Johnson: PharmaVitae ... IntroductionThis analysis examines the historical ... the prescription pharmaceutical sector. The profile encompasses global ...
... Reportlinker.com announces that a new market research ... Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile ... IntroductionThis analysis examines the historical ... pharmaceutical sector. The profile encompasses global company strategy, ...
Cached Medicine Technology:Reportlinker Adds Johnson & Johnson: PharmaVitae Profile 2Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile 2
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... Tampa, Florida (PRWEB) April 17, 2015 ... Term Acute Care and Florida Hospital Carrollwood were all ... Hospital Wesley Chapel, located in Pasco County, is ranked ... Bay Times workplaces survey, which was conducted in partnership ... is an 83 all-private bed hospital that opened in ...
(Date:4/17/2015)... San Jose, CA (PRWEB) April 17, 2015 ... of life insurance protection without modifications can now use ... are now general life insurance policy rates that are ... . , The standard plans that are offered are ... for adults aged 18 to 79. There are now ...
(Date:4/17/2015)... 17, 2015 At the end of ... and the “Salute to the Oscars” in the Stardust ... Hotel, overlooking the impressive Los Angeles skyline. These events ... Debbie Durkin, LA’s leading producer of sustainable product placement ... the world’s premier providers of eco-friendly and socially conscious ...
(Date:4/17/2015)... Organic Valley, the nation’s largest cooperative ... International Year of Soils by “Cycling for Sustainability” through ... employees will travel 215 miles from Auburn, California, to ... about the impact of agriculture on water and soil ... Maine, Wisconsin, Oregon, and Washington state, the cyclists have ...
Breaking Medicine News(10 mins):Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3
... Choice Act, Spark Major Drive for Healthcare Union Organizing, ... Calif. and WASHINGTON, March 19 In ... pass the Employee Free Choice Act and rapidly promote ... International Union and the California Nurses Association/National ...
... Health Provisions , ... Newport Beach, CA. (PRWEB) March ... benefits management services , today released a summary of the ... face of the significant changes from Barack Obama’s new administration, Secova ...
... and homeopathic alternative for reducing the symptoms related ... (ADHD) without a prescription and without negative side ... medication use in children ages 5 to 19 ... researchers from the Saint Louis University School of ...
... March 19 The 2009 Frost & ... Product Quality Leadership Award is presented to ... Uncompromising quality maintenance, together with exceptional customer ... success. (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... is National Brain Injury Awareness MonthWHEATON, Ill., March 18 ... 3.8 million individuals in the U.S. each year according to ... a type of traumatic brain injury (TBI) caused by a ... mild to severe. It is important to note that even ...
... playsPHOENIX, March 18 Gold Canyon, a leader ... Candle Game to benefit the Prayer Child Foundation. For every ... will donate 10 cents to help children facing physical and ... http://thecandlegame.com and through Facebook on Gold Canyon,s official ...
Cached Medicine News:Health News:SEIU, CNA/NNOC Announce Major Accord 2Health News:SEIU, CNA/NNOC Announce Major Accord 3Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 2Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 3Health News:Frost & Sullivan Product Quality Accolade for KIBI Software Solutions 2Health News:Frost & Sullivan Product Quality Accolade for KIBI Software Solutions 3Health News:Sports Concussions: Common and Preventable 2Health News:Gold Canyon Ignites Hope With Online Charity Candle Game 2
Adjustable speed vortex with inter-changeable heads , 110 V...
Inquire...
Adjustable speed vortex with inter-changeable heads, 110 V...
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Medicine Products: